StocksFin Logo
Abiomed, Inc. country of incorporation
|
|
Mr. Michael Minogue
|
2,003 employees
NASDAQ | Healthcare | Medical Devices
Bio-Techne Corporation country of incorporation
|
|
Mr. Charles Kummeth
|
3,000 employees
NASDAQ | Healthcare | Biotechnology
Q223 reported Nov 3, 2022 Reporting Period
$265.92M 7.2% vs. Q222 Revenues Q223
81.62% -0.8% vs. Q222 Gross Profit Margin
39.91% 73.9% vs. Q222 Net Profit Margin
7.81M -87.1% vs. Q222 Free Cash Flow Q223
$2.34 87.2% vs. Q222 EPS Q223
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q223
Q123
0.11%
Q123 reported Nov 7, 2022 Reporting Period
$269.66M 4.6% vs. Q122 Revenues Q123
66.6% 0.4% vs. Q122 Gross Profit Margin
33.21% 22.9% vs. Q122 Net Profit Margin
46.53M -3.9% vs. Q122 Free Cash Flow Q123
$0.55 30.6% vs. Q122 EPS Q123
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q223
Q123
0.11%
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
6.82
2.74
Current Ratio
7.93
4.01
Cash Ratio
1.36
1.2
Price to Book
7.24
6.36
Price to Sales
41.92
41.32
Price to Earnings
26.25
31.1